ArticleJournal of translational autoimmunity2025
A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis.
Atsushi Tanaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.